A224 Lenalidomide, Bortezomib, and Dexamethasone Has...

Clinical Lymphoma & Myeloma 2009 / 2 Vol. 9

A224 Lenalidomide, Bortezomib, and Dexamethasone Has Notable Activity in High-Risk First-Line Myeloma

Richardson, PG, Lonial, S, Jakubowiak, A, Jagannath, S, Raje, N, Avigan, D, Ghobrial, IM, Schlossman, R, Mazumder, A, Munshi, NC, Vesole, D, Joyce, R, Doss, D, Warren, D, Lunde, L, Lukas, R, Kaster, S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Language:
english
Journal:
Clinical Lymphoma and Myeloma
DOI:
10.1016/s1557-9190(11)70510-8
Date:
February, 2009
File:
PDF, 86 KB
english, 2009
Conversion to is in progress
Conversion to is failed